These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia. Wang Y, Nguyen FNHL, Allen JC, Lew JQL, Tan NC, Jafar TH. BMC Nephrol; 2019 Dec 04; 20(1):451. PubMed ID: 31801468 [Abstract] [Full Text] [Related]
4. Enhancing vascular access planning in CKD: validating the 40% KFRE threshold for predicting ESKD in a French retrospective cohort study. Ingwiller M, Keller N, Krummel T, Prinz E, Steinmetz L, Hannedouche T, Florens N. Clin Kidney J; 2024 Aug 04; 17(8):sfae220. PubMed ID: 39421238 [Abstract] [Full Text] [Related]
5. Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort. Kwek JL, Pang HQJ, Li H, Lim WWL, Choo JCJ, Choong HL, Foo MWY, Chan CM. Singapore Med J; 2022 Jun 04; 63(6):313-318. PubMed ID: 36043308 [Abstract] [Full Text] [Related]
6. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study. Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ. PLoS Med; 2019 Nov 04; 16(11):e1002955. PubMed ID: 31693662 [Abstract] [Full Text] [Related]
7. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study. Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, Shaw JE. Am J Kidney Dis; 2018 Nov 04; 72(5):653-661. PubMed ID: 29784612 [Abstract] [Full Text] [Related]
13. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study. Stack AG, Johnson ME, Blak B, Klein A, Carpenter L, Morlock R, Maguire AR, Parsons VL. BMJ Open; 2019 Aug 28; 9(8):e031550. PubMed ID: 31462487 [Abstract] [Full Text] [Related]
14. CKD stage-specific utility of two equations for predicting 1-year risk of ESKD. Zheng S, Parikh RV, Tan TC, Pravoverov L, Patel JK, Horiuchi KM, Go AS. PLoS One; 2023 Aug 28; 18(11):e0293293. PubMed ID: 37910454 [Abstract] [Full Text] [Related]
16. A prediction model on incident ESKD among individuals with T2D and CKD. Lin Y, Shao H, Fonseca V, Anderson AH, Batuman V, Shi L. J Diabetes Complications; 2023 Apr 28; 37(4):108450. PubMed ID: 36871314 [Abstract] [Full Text] [Related]
18. Validation of the kidney failure risk equation in European CKD patients. Peeters MJ, van Zuilen AD, van den Brand JA, Bots ML, Blankestijn PJ, Wetzels JF, MASTERPLAN Study Group. Nephrol Dial Transplant; 2013 Jul 28; 28(7):1773-9. PubMed ID: 23645476 [Abstract] [Full Text] [Related]
19. Use of Histologic Parameters to Predict Glomerular Disease Progression: Findings From the China Kidney Biopsy Cohort Study. Zhang X, Luo F, Chen R, Shen J, Liu X, Shi Y, Yang Q, Huang T, Li H, Hu Y, Wan Q, Chen C, Jia N, Cao Y, Li Y, Zhao H, Su L, Gao P, Xu X, Nie S, Hou FF. Am J Kidney Dis; 2023 Apr 28; 81(4):416-424.e1. PubMed ID: 36252881 [Abstract] [Full Text] [Related]
20. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD). Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP, Holt SG. Nephrol Dial Transplant; 2013 Jun 28; 28(6):1569-79. PubMed ID: 23328709 [Abstract] [Full Text] [Related] Page: [Next] [New Search]